Global Parkinson’s Disease Therapeutics Market Insights, Forecast to 2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Parkinson’s Disease Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oral
  • 1.4.3 Transdermal
  • 1.4.4 Subcutaneous
  • 1.4.5 Intestinal Infusion
• 1.5 Market by Application
  • 1.5.1 Global Parkinson’s Disease Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2015-2026)
• 2.2 Global Parkinson’s Disease Therapeutics Growth Trends by Regions
  • 2.2.1 Parkinson’s Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Parkinson’s Disease Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Parkinson’s Disease Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Parkinson’s Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Parkinson’s Disease Therapeutics Players by Market Size
  • 3.1.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Parkinson’s Disease Therapeutics Market Concentration Ratio
  • 3.2.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2019
• 3.3 Parkinson’s Disease Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Parkinson’s Disease Therapeutics Product Solution and Service
• 3.5 Date of Enter into Parkinson’s Disease Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 6.2 Parkinson’s Disease Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 7.2 Parkinson’s Disease Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 8.2 Parkinson’s Disease Therapeutics Key Players in China (2019-2020)
• 8.3 China Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 8.4 China Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 9.2 Parkinson’s Disease Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 10.2 Parkinson’s Disease Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 11.2 Parkinson’s Disease Therapeutics Key Players in India (2019-2020)
• 11.3 India Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 11.4 India Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Parkinson’s Disease Therapeutics Market Size (2015-2020)
• 12.2 Parkinson’s Disease Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Parkinson’s Disease Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Parkinson’s Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbvie
  • 13.1.1 Abbvie Company Details
  • 13.1.2 Abbvie Business Overview
  • 13.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction
  • 13.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2015-2020))
  • 13.1.5 Abbvie Recent Development
• 13.2 Biogen
  • 13.2.1 Biogen Company Details
  • 13.2.2 Biogen Business Overview
  • 13.2.3 Biogen Parkinson’s Disease Therapeutics Introduction
  • 13.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.2.5 Biogen Recent Development
• 13.3 Boehringer Ingelheim GmbH
  • 13.3.1 Boehringer Ingelheim GmbH Company Details
  • 13.3.2 Boehringer Ingelheim GmbH Business Overview
  • 13.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction
  • 13.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim GmbH Recent Development
• 13.4 F. Hoffman-La Roche
  • 13.4.1 F. Hoffman-La Roche Company Details
  • 13.4.2 F. Hoffman-La Roche Business Overview
  • 13.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction
  • 13.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.4.5 F. Hoffman-La Roche Recent Development
• 13.5 GlaxoSmithKline
  • 13.5.1 GlaxoSmithKline Company Details
  • 13.5.2 GlaxoSmithKline Business Overview
  • 13.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction
  • 13.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.5.5 GlaxoSmithKline Recent Development
• 13.6 H. Lundbeck A/S
  • 13.6.1 H. Lundbeck A/S Company Details
  • 13.6.2 H. Lundbeck A/S Business Overview
  • 13.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction
  • 13.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.6.5 H. Lundbeck A/S Recent Development
• 13.7 Impax Labs
  • 13.7.1 Impax Labs Company Details
  • 13.7.2 Impax Labs Business Overview
  • 13.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction
  • 13.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.7.5 Impax Labs Recent Development
• 13.8 Newron Pharmaceuticals SpA
  • 13.8.1 Newron Pharmaceuticals SpA Company Details
  • 13.8.2 Newron Pharmaceuticals SpA Business Overview
  • 13.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction
  • 13.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.8.5 Newron Pharmaceuticals SpA Recent Development
• 13.9 Novartis AG
  • 13.9.1 Novartis AG Company Details
  • 13.9.2 Novartis AG Business Overview
  • 13.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction
  • 13.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.9.5 Novartis AG Recent Development
• 13.10 Orion Corporation
  • 13.10.1 Orion Corporation Company Details
  • 13.10.2 Orion Corporation Business Overview
  • 13.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction
  • 13.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 13.10.5 Orion Corporation Recent Development
• 13.11 Teva Pharmaceutical Industries Ltd.
  • 10.11.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 10.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
  • 10.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction
  • 10.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 10.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
• 13.12 UCB S.A.
  • 10.12.1 UCB S.A. Company Details
  • 10.12.2 UCB S.A. Business Overview
  • 10.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction
  • 10.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2015-2020)
  • 10.12.5 UCB S.A. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer